Regions Financial Corp Abb Vie Inc. Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Regions Financial Corp holds 412,529 shares of ABBV stock, worth $72.4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

412,529

Previous 407,592 1.21%

Holding current value

$72.4 Million

Previous $69.9 Million 16.53%

% of portfolio

0.59%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $808,878 - $984,092	4,937 Added 1.21%	412,529 $81.5 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $31.2 Million - $36.5 Million	201,676 Added 97.94%	407,592 $69.9 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $1.18 Million - $1.34 Million	7,371 Added 3.71%	205,916 $37.5 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $916,553 - $1.03 Million	-6,661 Reduced 3.25%	198,545 $30.8 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $744,229 - $861,555	-5,571 Reduced 2.64%	205,206 $30.6 Million
Q2 2023 Aug 09, 2023	BUY	$132.51 - $164.9 $1.2 Million - $1.5 Million	9,070 Added 4.5%	210,777 $28.4 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $3.75 Million - $4.32 Million	-25,955 Reduced 11.4%	201,707 $32.1 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $1.33 Million - $1.6 Million	-9,627 Reduced 4.06%	227,662 $36.8 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $2.54 Million - $2.92 Million	-18,952 Reduced 7.4%	237,289 $31.8 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $3.43 Million - $4.37 Million	-24,951 Reduced 8.87%	256,241 $39.2 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $11.4 Million - $14.1 Million	-86,403 Reduced 23.5%	281,192 $45.6 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $29.4 Million - $37.2 Million	-273,864 Reduced 42.69%	367,595 $49.8 Million
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $1.86 Million - $2.12 Million	-17,522 Reduced 2.66%	641,459 $69.2 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $598,434 - $666,690	-5,688 Reduced 0.86%	658,981 $74.2 Million
Q1 2021 Jun 02, 2021	BUY	$102.3 - $112.62 $599,375 - $659,840	5,859 Added 0.89%	664,669 $71.9 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $158,082 - $213,427	1,964 Added 0.3%	658,810 $70.6 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $1.05 Million - $1.23 Million	12,176 Added 1.89%	656,846 $57.5 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $2.51 Million - $3.36 Million	34,189 Added 5.6%	644,670 $63.3 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $26.1 Million - $39.5 Million	404,295 Added 196.08%	610,481 $46.5 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $11,829 - $14,801	-164 Reduced 0.08%	206,186 $18.3 Million
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $1.11 Million - $1.34 Million	-17,693 Reduced 7.9%	206,350 $15.6 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $465,813 - $595,418	7,090 Added 3.27%	224,043 $16.3 Million
Q1 2019 Apr 19, 2019	SELL	$77.14 - $90.79 $1.84 Million - $2.17 Million	-23,853 Reduced 9.91%	216,953 $17.5 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $163,173 - $201,236	-2,096 Reduced 0.86%	240,806 $22.2 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $199,691 - $221,994	2,246 Added 0.93%	242,902 $23 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $162,771 - $192,594	1,813 Added 0.76%	240,656 $22.3 Million
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $2.15 Million - $2.87 Million	-23,321 Reduced 8.9%	238,843 $22.6 Million
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $478,698 - $524,932	-5,345 Reduced 2.0%	262,164 $25.4 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $18.7 Million - $23.9 Million	267,509	267,509 $23.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Abb Vie Inc. Transaction History